Prognosis
EU Demands Access to AstraZeneca’s U.K. Vaccine Supplies in Call
- Politicians want details on delays to delivery of Covid doses
- Sluggish vaccine campaign has put governments on the defensive
This article is for subscribers only.
A chaotic showdown between AstraZeneca Plc and the European Union is coming to a head in a high stakes meeting on Wednesday with EU officials demanding the company tap British production facilities to make up for shortfalls in supply to the continent.
The public fight has epitomized the bloc’s failure to put its mass vaccination campaign on the right track, and cast doubt on its hopes to inoculate millions speedily and exit recession-inducing lockdowns. The row was triggered by the drugmaker’s announcement that vaccine deliveries to Europe will be lower than previously anticipated.